153 related articles for article (PubMed ID: 29575908)
1. Serum matrix metalloproteinase-9 level as a biomarker for colorectal cancer: a diagnostic meta-analysis.
Liang S; Chang L
Biomark Med; 2018 Apr; 12(4):393-402. PubMed ID: 29575908
[TBL] [Abstract][Full Text] [Related]
2. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
[TBL] [Abstract][Full Text] [Related]
3. TIMP-1 is a novel serum biomarker for the diagnosis of colorectal cancer: A meta-analysis.
Meng C; Yin X; Liu J; Tang K; Tang H; Liao J
PLoS One; 2018; 13(11):e0207039. PubMed ID: 30458003
[TBL] [Abstract][Full Text] [Related]
4. Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening.
Otero-Estévez O; De Chiara L; Rodríguez-Girondo M; Rodríguez-Berrocal FJ; Cubiella J; Castro I; Hernández V; Martínez-Zorzano VS
Sci Rep; 2015 Aug; 5():13030. PubMed ID: 26264519
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients.
Groblewska M; Mroczko B; Gryko M; Kędra B; Szmitkowski M
Folia Histochem Cytobiol; 2010 Dec; 48(4):564-71. PubMed ID: 21478099
[TBL] [Abstract][Full Text] [Related]
6. The association between the serum levels of matrix metalloproteinase 9 and colorectal cancer.
Rašić I; Rašić A; Akšamija G; Radović S; Šehović N
Med Glas (Zenica); 2017 Aug; 14(2):229-235. PubMed ID: 28644426
[TBL] [Abstract][Full Text] [Related]
7. Relationship of serum MMP-7 levels for colorectal cancer: a meta-analysis.
Xing XJ; Gu XH; Ma TF
Tumour Biol; 2014 Oct; 35(10):10515-22. PubMed ID: 25060179
[TBL] [Abstract][Full Text] [Related]
8. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
Xu F; Xu L; Wang M; An G; Feng G
Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
[TBL] [Abstract][Full Text] [Related]
9. High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
Peltonen R; Hagström J; Tervahartiala T; Sorsa T; Haglund C; Isoniemi H
Oncology; 2021; 99(3):144-160. PubMed ID: 33027796
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic values of MMP-7, MMP-9, MMP-11, TIMP-1, TIMP-2, CEA, and CA19-9 in patients with colorectal cancer.
Huang X; Lan Y; Li E; Li J; Deng Q; Deng X
J Int Med Res; 2021 May; 49(5):3000605211012570. PubMed ID: 33942633
[TBL] [Abstract][Full Text] [Related]
11. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
[TBL] [Abstract][Full Text] [Related]
12. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
[TBL] [Abstract][Full Text] [Related]
13. Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer.
Li C; Wang X; Casal I; Wang J; Li P; Zhang W; Xu E; Lai M; Zhang H
J Cell Mol Med; 2016 Aug; 20(8):1420-6. PubMed ID: 26990020
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in preoperative serum as independent prognostic markers in patients with colorectal cancer.
Dragutinović VV; Radonjić NV; Petronijević ND; Tatić SB; Dimitrijević IB; Radovanović NS; Krivokapić ZV
Mol Cell Biochem; 2011 Sep; 355(1-2):173-8. PubMed ID: 21541674
[TBL] [Abstract][Full Text] [Related]
15. Is serum matrix metalloproteinase 9 a useful biomarker in detection of colorectal cancer? Considering pre-analytical interference that may influence diagnostic accuracy.
Jung K
Br J Cancer; 2008 Aug; 99(3):553-4; author reply 555. PubMed ID: 18648367
[No Abstract] [Full Text] [Related]
16. Detection of microRNA-21 expression as a potential screening biomarker for colorectal cancer: a meta-analysis.
Jiang JX; Zhang N; Liu ZM; Wang YY
Asian Pac J Cancer Prev; 2014; 15(18):7583-8. PubMed ID: 25292032
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of circulating miR-21 for colorectal cancer: a meta-analysis.
Shan L; Ji Q; Cheng G; Xia J; Liu D; Wu C; Zhu B; Ding Y
Cancer Biomark; 2015; 15(1):47-56. PubMed ID: 25524942
[TBL] [Abstract][Full Text] [Related]
18. Plasma matrix metalloproteinase 9 as an early surrogate biomarker of advanced colorectal neoplasia.
Gimeno-García AZ; Triñanes J; Quintero E; Salido E; Nicolás-Pérez D; Adrián-de-Ganzo Z; Alarcón-Fernández O; Abrante B; Romero R; Carrillo M; Ramos L; Alonso I; Ortega J; Jiménez A
Gastroenterol Hepatol; 2016; 39(7):433-41. PubMed ID: 26601990
[TBL] [Abstract][Full Text] [Related]
19. Circulating fibrinogen to pre-albumin ratio is a promising biomarker for diagnosis of colorectal cancer.
Sun F; Tan YA; Gao QF; Li SQ; Zhang J; Chen QG; Jiang YH; Zhang L; Ying HQ; Wang XZ
J Clin Lab Anal; 2019 Jan; 33(1):e22635. PubMed ID: 30047185
[TBL] [Abstract][Full Text] [Related]
20. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
Bilegsaikhan E; Liu HN; Shen XZ; Liu TT
J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
